No results for ‘’
Hester Biosciences Ltd
NSE: HESTERBIO BSE: 524669
₹2076.40
(0.86%)
Mon, 22 Jun 2026, 09:50 pm
Market Cap (in Cr)1747.01
PE Ratio31.75
Dividend0.34
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1987
- The Company was incorporated as a Private Limited Company.
1993
- The Company was converted into a Public Limited Company.
1994
- The company came out with a Public Issue of 21,40,000 equity shares.
1997
- The company created an excellent manufacturing facility to produce Animal Vaccines.
1999
- Mr. Vinod Agarwala resigned as Director due to personal reasons.
- Mr. A.C. Patel was appointed as a Nominee Director of Gujarat Industrial Investment Corporation Limited.
- Mr. Ravin Gandhi and Ms. Bela Gandhi were appointed as additional Directors.
2000
- Hester Pharmaceuticals Ltd entered into a contract manufacturing agreement with Sinsui Inc.
2004
- Hester Pharmaceuticals Ltd was delisted from Ahmedabad Stock Exchange.
2008
- The company name was changed from Hester Pharmaceuticals Ltd to Hester Biosciences Ltd.
- Hester Biosciences Ltd issued rights in the Ratio of 2:5.
2010
- Hester Biosciences appointed Mr. Vishvesh Patel as a Non-Executive Independent Director.
2011
- Hester Biosciences recommended a Dividend of Rs. 3.50 per equity share of Rs. 10 each.
2012
- Hester entered into a Business Transfer Agreement with Innoves Animal Health Private Limited.
- Hester Biosciences gave a bonus in the Ratio of 1:2.
2013
- Hester Biosciences received WHO GMP Certification.
- Hester launched Bivalent Marek's Disease Live Vaccine.
2014
- Hester Biosciences board approved a scheme of amalgamation.
- The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015
- Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020
- Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021
- Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.